For the financial period ending December 31 2022 company lost money of $-1.57 per share compare to $-1.97 a year before and from $0.00 per share from the preceding quarter.

Revenues fell sharply by -79.83 % to $0.17 millions from $0.82 millions in the similar quarter a year before and sequentially from $0.00 millions.




For the financial period ending December 31 2022 Autolus Therapeutics Plc realized net deficit of $-148.839 million, bigger than $-142.096 million a year ago.

Additionally, the AUTL claimed as well a shortfall of $-148.84 millions and for the fiscal year 2022, Revenues of $0.17 millions.

Biotechnology & Pharmaceuticals The Biotechnology & Pharmaceuticals company has decreased it's deficit per share to $-1.57 from $-1.97 in the preceding fiscal year, while by -79.83 % from $0.82 millions a year before.

Autolus Therapeutics Plc is expected to report next financial earnings on March 06, 2024.